ScholarLens Back to search
2007•HaematologicaOpen access

Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia

Alexander W. Hauswirth, Ulrich Jäger

Open full text 14 citations

Abstract

The prognosis of patients with B-cell chronic lymphocytic leukemia (B-CLL) has long been determined by the clinical staging systems of Binet and Rai.[1][1]–[4][2] Unfortunately, these systems fail to identify patients in early stages whose disease will rapidly progress. Neither can this approach

Open-access reader

About this research paper

What this paper is about

The prognosis of patients with B-cell chronic lymphocytic leukemia (B-CLL) has long been determined by the clinical staging systems of Binet and Rai.[1][1]–[4][2] Unfortunately, these systems fail to identify patients in early stages whose disease will rapidly progress. Neither can this approach

Why it matters

OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The prognosis of patients with B-cell chronic lymphocytic leukemia (B-CLL) has long been determined by the clinical staging systems of Binet and Rai.[1][1]–[4][2] Unfortunately, these systems fail to identify patients in early stages whose disease will rapidly progress. Neither can this approach

Key concepts: Chronic lymphocytic leukemia, Medicine, Leukemia, Cytogenetics, Chronic leukemia, Disease, Oncology, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia — Research Paper | ScholarLens